OncoSil Medical Limited (ASX:OSL)

OncoSil Medical Revenue

In the fiscal year ending June 30, 2025, OncoSil Medical had annual revenue of 1.54M AUD, down -1.92%. OncoSil Medical had revenue of 549.88K in the half year ending June 30, 2025, a decrease of -16.41%.

• Revenue: 1.54M
• Revenue Growth: -1.92%
• P/S Ratio: 18.39
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 28.24M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2025	1.54M	-30.12K	-1.92%
Jun 30, 2024	1.57M	97.96K	6.68%
Jun 30, 2023	1.47M	404.03K	38.00%
Jun 30, 2022	1.06M	-234.94K	-18.10%
Jun 30, 2021	1.30M	-1.47M	-53.02%